AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference

SAN DIEGO, Sept. 27, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the Cantor Fitzgerald Global 2019 Healthcare Conference on Wednesday, Oct. 2, 2019 at 5:20 p.m. ET in New York City.